Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimenhydrinate vs Ondansetron for PONV
NCT05590936Completed
- Sponsor
- University of Thessaly
- Start
- Jan 2018
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dimenhydrinate in postoperative nausea and vomiting (PONV) (2 arms), sponsored by University of Thessaly. Primary endpoint: Postoperative Nausea and Vomiting at 24 hours. Started Jan 2018; status: completed.
02
Drugs
dimenhydrinate
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05590936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590936.